33 citations · 55 across the 2 of their papers we have counts for
2 papers
q-bio.GN2013★ 33 cited
KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach
Pawel Domagala, Jolanta Hybiak, Violetta Sulzyc-Bielicka +3
Identifying targets for personalized targeted therapy is the pathologist's domain and a treasure. For decades, pathologists have had to learn, understand, adopt and implement many…
q-bio.SC2012★ 22 cited
Colorectal cancers differ in respect of PARP-1 protein expression
Violetta Sulzyc-Bielicka, Pawel Domagala, Jolanta Hybiak +3
Recent findings raise the possibility of PARP inhibitor therapy in colorectal cancers(CRCs). However, the extent of PARP-1 protein expression in clinical specimens of CRC is not kn…